SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000898432-19-001240
Filing Date
2019-10-10
Accepted
2019-10-10 17:30:48
Documents
1
Period of Report
2019-10-10

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 3905
  Complete submission text file 0000898432-19-001240.txt   5449
Mailing Address P.O. BOX 23350 SEATTLE WA 98102
Business Address 500 5TH AVE NORTH SEATTLE WA 98109 206-709-3100
Bill & Melinda Gates Foundation (Reporting) CIK: 0001663801 (see all company filings)

State of Incorp.: WA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39083 | Film No.: 191146734

Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)